Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam, Inc. - Common Stock
(NQ:
BEAT
)
2.020
UNCHANGED
Streaming Delayed Price
Updated: 10:50 AM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heartbeam, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
January 05, 2023
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Shareholder Letter, Including Corporate Update
December 29, 2022
Via
Investor Brand Network
Exposures
Product Safety
HeartBeam Issues Shareholder Letter and Provides Corporate Update
December 29, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology
December 21, 2022
Via
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Looks to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
December 20, 2022
By Spotlight Growth
Via
News Direct
HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection
December 19, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Renowned Cardiologist to Help Define Best Paths to Advance Products
December 16, 2022
Via
Investor Brand Network
HeartBeam (NASDAQ: BEAT) Looks to Disrupt Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
December 15, 2022
Monitoring a patient’s heart condition is an extensive undertaking considering the current standard of care practices. Up until a few years ago, heart patients seeking to have their condition monitored...
Via
Benzinga
HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
December 15, 2022
Monitoring a patient’s heart condition is an extensive undertaking considering the current standard of care practices. Up until a few
Via
Spotlight Growth
HeartBeam (NASDAQ: BEAT): Innovative Technologies Disrupting the Old Standard of Care for Heart Patients and Upgrading ECG for the 21st Century
December 08, 2022
The heart is one of the most essential organs that propel life by pumping blood throughout the body and supporting
Via
Spotlight Growth
Topics
Death
Exposures
Death
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Signs Agreement to Build Exclusive AIMIGo 12-Lead 3D VECG Device
December 07, 2022
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
HeartBeam (NASDAQ: BEAT) Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
December 07, 2022
SANTA CLARA, Calif., December 07, 2022--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and
Via
Spotlight Growth
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
December 07, 2022
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Recognized for ‘Unique Approach to Heart Attack Diagnosis’
December 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
December 02, 2022
Via
Benzinga
HeartBeam Inc. (NASDAQ: BEAT) Announces New Chief Medical Officer
November 23, 2022
Via
Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Awarded Top Honors for Game-Changing Cardiovascular Tech Platform
November 21, 2022
Via
Investor Brand Network
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
Via
Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Growing Portfolio with Valuable New Patent
November 16, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart Attacks
November 16, 2022
HeartBeam Inc (NASDAQ: BEAT) announced that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended to detect heart attacks and complex cardiac arrhythmias was allowed by the...
Via
Benzinga
New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
November 16, 2022
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2022 Financial Report
November 11, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
HeartBeam Reports Third Quarter 2022 Financial Results
November 10, 2022
From
HeartBeam, Inc.
Via
Business Wire
Study Finds Covid-19 Spikes Linked to Increases in Heart Attacks
November 02, 2022
Via
Investor Brand Network
Exposures
COVID-19
Study Finds Smart Watches Can Accurately Detect Atrial Fibrillation
October 26, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 25, 2022
Gainers
Via
Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 2022 Results Conference Call
October 25, 2022
Via
Investor Brand Network
HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern Time
October 25, 2022
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Patented Breakthrough Technology Poised to Disrupt ECG Patch Market
October 21, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.